Article
Author(s):
Top news of the day from across the healthcare landscape.
According to Kaiser Health News, a recent study found that patients with complex and expensive diseases have better access to specialty drugs. However, patients who have silver-level plans are experiencing high out-of-pocket costs for expensive specialty drugs for conditions such as HIV, cancer, hepatitis C, and bipolar disorder. These drugs are typically placed in a tier that requires the patient to pay up to 40% or more of the drug, rather than a copay.
The governor of Arkansas used a line-item veto on Thursday in order to continue the state’s Medicaid expansion. According to Kaiser Health News, the state’s Medicaid expansion covers over 267,000 people who are 138% below poverty level. This veto ended a budget standoff that lasted for 2 weeks.
According to the Los Angeles Times, Target pharmacy was recently taken over by CVS Health, with one customer finding a 380% price increase in his prescription. A CVS spokesperson stated that the pharmacy is not to blame and it is the fault of third-party companies that offer discount card programs. Drug price fluctuation is also common, the article states.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.